BENIPROSIN Capsule Ref.[115227] Active ingredients: Tamsulosin

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2021  Publisher: Ranbaxy Pharmaceuticals {Pty) Ltd, 14 Lautre Road, Stormill Ext 1, Roodepoort, 1724, South Africa

Product name and form

BENIPROSIN SR (Capsule 0,4 mg).

Pharmaceutical Form

Capsule.

Brown, opaque cap/orange opaque body, of size ‘2’ imprinted with ‘R’ on cap and ‘TSN400’ on body in black edible ink, containing white to off-white granular beads.

Qualitative and quantitative composition

BENIPROSIN SR.

Each capsule contains tamsulosin hydrochloride 0,4 mg.

Sugar free.

For full list of excipients, see section 6.1.

Active Ingredient

Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow.

List of Excipients

Tamsulosin hydrochloride beads:

Magnesium stearate, methycrylic acid-ethyl acrylate copolymer (1:1) dispersion, microcrystalline cellulose (PH101)

Enteric coating:

Methycrylic acid-ethyl acrylate copolymer (1:1), sodium hydroxide, triacetin, talc,

Extra granular:

Talc

Capsule Shell:

Brown cap/Orange body size 2

Body composition:

Brilliant blue (Cl No 42090), gelatin; poncrea 4R (Cl No 16255), quinolone yellow (Cl No 470005), sunset yellow (Cl No 15985), titanium dioxide (Cl No 77891)

Cap Composition:

Brilliant blue (Cl No 42090), carmosine (Cl No14720), gelatin, titanium dioxide (Cl 77891); yellow iron oxide (Cl No 77891)

Printing Ink-1:

Activated charcoal, alcohol (ethanol)#, isopropyl alcohol#, shellac

Printing Ink-2 & 3:

Tekprint SW-9007 or Tekprint SW-9008

Black iron oxide (E172), butyl alcohol, dehydrated alcohol, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, strong ammonia solution

# Used as solvent an lost during processing

Pack sizes and marketing

Cartons containing 10, 30 or 60 capsules packed in blister strips. The blister strip consists of clear, transparent film of PVC coated with PVdC with a backing of aluminium foil.

Marketing authorization holder

Ranbaxy Pharmaceuticals {Pty) Ltd, 14 Lautre Road, Stormill Ext 1, Roodepoort, 1724, South Africa

Marketing authorization dates and numbers

A40/34/0211

09 December 2008

Drugs

Drug Countries
BENIPROSIN South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.